Free Trial

Monogram Orthopaedics (MGRM) Competitors

Monogram Orthopaedics logo
$5.73 0.00 (0.00%)
As of 03:40 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

MGRM vs. INMD, IRMD, EMBC, TNDM, KMTS, BBNX, AXGN, SIBN, BVS, and AVNS

Should you be buying Monogram Orthopaedics stock or one of its competitors? The main competitors of Monogram Orthopaedics include InMode (INMD), iRadimed (IRMD), Embecta (EMBC), Tandem Diabetes Care (TNDM), Kestra Medical Technologies (KMTS), Beta Bionics (BBNX), AxoGen (AXGN), SiBone (SIBN), Bioventus (BVS), and Avanos Medical (AVNS). These companies are all part of the "medical equipment" industry.

Monogram Orthopaedics vs. Its Competitors

InMode (NASDAQ:INMD) and Monogram Orthopaedics (NASDAQ:MGRM) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, earnings, dividends, institutional ownership, analyst recommendations, risk, media sentiment and profitability.

68.0% of InMode shares are owned by institutional investors. Comparatively, 0.4% of Monogram Orthopaedics shares are owned by institutional investors. 6.9% of InMode shares are owned by insiders. Comparatively, 28.1% of Monogram Orthopaedics shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

InMode has a beta of 2, meaning that its stock price is 100% more volatile than the S&P 500. Comparatively, Monogram Orthopaedics has a beta of 0.69, meaning that its stock price is 31% less volatile than the S&P 500.

InMode has a net margin of 44.50% compared to Monogram Orthopaedics' net margin of 0.00%. InMode's return on equity of 18.38% beat Monogram Orthopaedics' return on equity.

Company Net Margins Return on Equity Return on Assets
InMode44.50% 18.38% 16.35%
Monogram Orthopaedics N/A -126.82%-96.87%

In the previous week, InMode had 4 more articles in the media than Monogram Orthopaedics. MarketBeat recorded 6 mentions for InMode and 2 mentions for Monogram Orthopaedics. InMode's average media sentiment score of 1.46 beat Monogram Orthopaedics' score of 0.97 indicating that InMode is being referred to more favorably in the media.

Company Overall Sentiment
InMode Positive
Monogram Orthopaedics Positive

InMode presently has a consensus target price of $18.04, indicating a potential upside of 19.84%. Monogram Orthopaedics has a consensus target price of $5.40, indicating a potential downside of 6.57%. Given InMode's higher possible upside, analysts clearly believe InMode is more favorable than Monogram Orthopaedics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
InMode
0 Sell rating(s)
7 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.13
Monogram Orthopaedics
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
3.50

InMode has higher revenue and earnings than Monogram Orthopaedics. Monogram Orthopaedics is trading at a lower price-to-earnings ratio than InMode, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
InMode$401.56M2.37$181.27M$2.476.10
Monogram OrthopaedicsN/AN/A-$16.33M-$0.50-11.56

Summary

InMode beats Monogram Orthopaedics on 12 of the 15 factors compared between the two stocks.

Get Monogram Orthopaedics News Delivered to You Automatically

Sign up to receive the latest news and ratings for MGRM and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MGRM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MGRM vs. The Competition

MetricMonogram OrthopaedicsMED INSTRUMENTS IndustryMedical SectorNASDAQ Exchange
Market Cap$234.85M$6.80B$5.81B$10.17B
Dividend YieldN/A1.23%5.69%4.61%
P/E Ratio-11.5625.9674.6226.02
Price / SalesN/A62.86466.0690.52
Price / CashN/A21.6337.0859.91
Price / Book13.764.9812.166.30
Net Income-$16.33M$176.38M$3.29B$270.86M
7 Day Performance1.23%1.18%1.07%3.41%
1 Month Performance7.64%3.39%7.38%6.56%
1 Year Performance83.49%12.55%63.13%28.27%

Monogram Orthopaedics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MGRM
Monogram Orthopaedics
1.8619 of 5 stars
$5.73
flat
$5.40
-5.8%
+70.5%$233.43MN/A-11.4928Positive News
Short Interest ↓
INMD
InMode
3.0559 of 5 stars
$14.64
-2.0%
$18.04
+23.3%
-9.2%$922.23M$394.82M5.91480Positive News
IRMD
iRadimed
4.8063 of 5 stars
$71.78
-0.9%
$72.00
+0.3%
+58.9%$912.98M$73.24M44.31110Positive News
Short Interest ↓
EMBC
Embecta
4.5122 of 5 stars
$14.38
-0.9%
$19.00
+32.2%
-1.7%$851.15M$1.12B10.182,100Positive News
TNDM
Tandem Diabetes Care
4.4939 of 5 stars
$12.67
+1.2%
$22.47
+77.4%
-70.1%$851.11M$940.20M-4.082,650Positive News
KMTS
Kestra Medical Technologies
1.609 of 5 stars
$15.90
-1.5%
$27.33
+71.9%
N/A$816.47M$59.81M0.00300News Coverage
Positive News
Gap Up
BBNX
Beta Bionics
1.0921 of 5 stars
$18.60
-1.3%
$22.56
+21.3%
N/A$808.54M$65.12M0.00294
AXGN
AxoGen
2.8944 of 5 stars
$15.97
-1.1%
$26.00
+62.8%
+26.5%$735.15M$187.34M-159.76450Positive News
SIBN
SiBone
3.7856 of 5 stars
$16.59
-0.5%
$23.67
+42.7%
+8.2%$715.48M$167.18M-29.62350Positive News
BVS
Bioventus
1.0138 of 5 stars
$7.40
+2.1%
N/AN/A$611.83M$573.28M14.801,200
AVNS
Avanos Medical
2.1298 of 5 stars
$11.77
-1.4%
N/A-47.3%$550.07M$687.80M-1.182,227Positive News

Related Companies and Tools


This page (NASDAQ:MGRM) was last updated on 9/12/2025 by MarketBeat.com Staff
From Our Partners